Form 4: Amprius Director Sells Shares After Option Exercise
Insider Trading Report
Amprius Technologies Director Wen Hsuan Hsieh exercised stock options and subsequently sold a significant number of common shares.
Summary
- Director Wen Hsuan Hsieh exercised options to acquire 270,251 shares of Amprius Technologies common stock at $2.61 per share on March 12, 2026.
- Hsieh then sold 282,500 shares at an average price of $18.546 per share on March 12, 2026, with prices ranging from $18.45 to $18.78.
- An additional 130,646 shares were sold at an average price of $18.2232 per share on March 12, 2026, with prices ranging from $18.12 to $18.39.
- Following these transactions, Hsieh's direct beneficial ownership of common stock is effectively zero, with 44,444 restricted stock units remaining as beneficial ownership.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a moderately negative signal due to the significant net sale of shares by a director, which reduces their direct equity alignment with shareholders, despite being a personal financial decision.
Positives
- The exercise price of $2.61 per share for the options indicates a significant in-the-money value compared to the sale prices of over $18 per share, demonstrating a profitable transaction for the director.
Negatives
- A director selling a substantial number of shares, particularly a net reduction in direct equity holdings (413,146 shares sold vs. 270,251 shares acquired), could be perceived negatively by the market as it reduces their direct equity alignment with shareholders.
Risks
- Insider selling, especially by a director, can sometimes signal a lack of confidence in the company's near-term prospects or a belief that the stock price is fully valued, potentially impacting investor sentiment.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, focusing solely on insider trading activity.
Management Comments
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.
Industry Context
StockSavvy.ai notes that insider selling, particularly a net reduction in direct equity holdings by a director, can sometimes be interpreted by the market as a signal, though it often relates to personal financial planning or diversification rather than a direct commentary on company performance. In the high-growth battery technology sector, investor sentiment is often sensitive to such signals.
Comparison to Industry Standards
- This Form 4 filing is a standard disclosure for insider transactions. While the specific transaction details are unique to Amprius Technologies and Director Hsieh, the act of exercising options and selling shares is a common practice for executives and directors across all industries, including technology and manufacturing. There are no direct comparable companies or projects mentioned in the filing to assess specific results against.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Wen Hsieh granted a Power of Attorney to Thomas M Stepien, Ricardo C. Rodriguez, and Siyu Jiang to prepare and file SEC forms (including Forms 3, 4, 5, 13D, 13G, and 144) on his behalf, and to manage his EDGAR account. | 2025-11-05 | This is a standard corporate governance practice to facilitate timely and accurate SEC filings for insiders, ensuring compliance with reporting obligations. |
Stakeholder Impact
- Shareholders: May interpret the director's net selling of shares as a potential signal regarding the company's valuation or future prospects, potentially influencing investor sentiment.
Next Steps
- The filing does not mention any specific future actions or milestones for the company, only the reporting person's undertaking to provide further transaction details upon request.
Key Dates
| Date | Description |
|---|---|
| 2025-11-05 | Date Power of Attorney was executed by Wen Hsieh. |
| 2026-03-12 | Date of stock option exercise and subsequent share sales. |
| 2026-03-13 | Date Form 4 was signed. |
| 2032-04-13 | Expiration date of the exercised stock option. |
Recommendation
holdWhile the director's significant net sale of shares after an option exercise could be perceived negatively, it's a single insider transaction and often driven by personal financial planning. Without additional company-specific news or broader market context, a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company developments before making a definitive buy or sell decision.
Keywords
Amprius Technologies, AMPX, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, Wen Hsuan Hsieh, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.